We are live on ! Find out more
SBSB

Sullivan, Bruyette, Speros & Blaney Portfolio holdings

AUM $2.27B
1-Year Est. Return 50.71%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+50.71%
3 Year Est. Return
+46.71%
5 Year Est. Return
+87.02%
10 Year Est. Return
AUM
$1.66B
AUM Growth
+$19.3M
Cap. Flow
-$25.1M
Cap. Flow %
-1.52%
Top 10 Hldgs %
76.95%
Holding
238
New
28
Increased
109
Reduced
63
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 3.09%
2 Healthcare 1.95%
3 Financials 1.32%
4 Energy 0.77%
5 Consumer Staples 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDY icon
126
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$498K 0.03%
4,941
+607
+14% +$60.7K
MDY icon
127
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$497K 0.03%
1,403
VOO icon
128
Vanguard S&P 500 ETF
VOO
$972B
$496K 0.03%
1,844
+758
+70% +$201K
NOW icon
129
ServiceNow
NOW
$114B
$488K 0.03%
8,880
PM icon
130
Philip Morris
PM
$299B
$488K 0.03%
6,212
-266
-4% -$22K
NOC icon
131
Northrop Grumman
NOC
$76B
$483K 0.03%
1,495
+69
+5% +$20.6K
JUST icon
132
Goldman Sachs JUST US Large Cap Equity ETF
JUST
$556M
$481K 0.03%
+11,438
New +$472K
VT icon
133
Vanguard Total World Stock ETF
VT
$76.9B
$472K 0.03%
6,279
+7
+0.1% +$519
INTU icon
134
Intuit
INTU
$86.3B
$465K 0.03%
1,780
+320
+22% +$81.3K
SGEN
135
DELISTED
Seagen Inc. Common Stock
SGEN
$463K 0.03%
6,689
GDX icon
136
VanEck Gold Miners ETF
GDX
$23.5B
$462K 0.03%
18,077
+7,201
+66% +$159K
GILD icon
137
Gilead Sciences
GILD
$163B
$455K 0.03%
6,736
+959
+17% +$63.1K
AXP icon
138
American Express
AXP
$228B
$451K 0.03%
3,656
PPG icon
139
PPG Industries
PPG
$24.9B
$448K 0.03%
3,842
-97
-2% -$11.1K
MO icon
140
Altria Group
MO
$113B
$447K 0.03%
9,445
-587
-6% -$30.7K
SCHB icon
141
Schwab US Broad Market ETF
SCHB
$43B
$446K 0.03%
37,920
-1,242
-3% -$14.3K
C icon
142
Citigroup
C
$222B
$439K 0.03%
6,263
+502
+9% +$33.6K
ADP icon
143
Automatic Data Processing
ADP
$105B
$428K 0.03%
2,587
+197
+8% +$32K
XLF icon
144
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$424K 0.03%
15,375
-2,078
-12% -$56.3K
CL icon
145
Colgate-Palmolive
CL
$73.3B
$419K 0.03%
5,847
-197
-3% -$14K
RVTY icon
146
Revvity
RVTY
$12.7B
$414K 0.03%
4,302
-1,398
-25% -$130K
CLX icon
147
Clorox
CLX
$11.7B
$407K 0.02%
2,656
+34
+1% +$5.19K
CRM icon
148
Salesforce
CRM
$148B
$406K 0.02%
2,676
+873
+48% +$137K
IDLV icon
149
Invesco S&P International Developed Low Volatility ETF
IDLV
$349M
$406K 0.02%
11,985
+71
+0.6% +$2.36K
LOW icon
150
Lowe's Companies
LOW
$118B
$405K 0.02%
4,018
+295
+8% +$31.1K

Similar funds

Sullivan, Bruyette, Speros & Blaney's Q2 2019 Portfolio in Review

As of Q2 2019, Sullivan, Bruyette, Speros & Blaney held 238 positions worth $1.66B, up 1.2% from $1.64B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Sullivan, Bruyette, Speros & Blaney's Q2 2019 filing shows 28 new, 109 increased, 63 reduced and 2 closed positions. Its largest new stake was Taubman Centers Inc.: 50,000 shares worth $2.04M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Financials.

  • Sullivan, Bruyette, Speros & Blaney's largest Q2 2019 buy was Taubman Centers Inc.: 50,000 shares worth $2.04M.
  • Sullivan, Bruyette, Speros & Blaney added most to Vanguard Extended Market ETF in Q2 2019, an estimated $2.95M increase.
  • Sullivan, Bruyette, Speros & Blaney's biggest Q2 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $17.9M.
  • Sullivan, Bruyette, Speros & Blaney fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q2 2019, selling an estimated $345K.
  • Sullivan, Bruyette, Speros & Blaney's ten largest holdings make up 77% of its $1.66B portfolio in Q2 2019.
  • Sullivan, Bruyette, Speros & Blaney opened 28 new positions and closed 2 in Q2 2019.
  • Sullivan, Bruyette, Speros & Blaney's portfolio value rose 1.2% quarter-over-quarter to $1.66B.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q2 2019, filed 5 Aug 2019.